To date, no other genome-wide study of MITF p.E318K RCC has been published, which will be necessary to identify additional genomic or epigenomic alterations and elucidate the molecular mechanisms of MITF p.E318K RCC pathogenesis. This evidence concerns the gene MITF and renal cell carcinoma.